posted
***PKTX...Protokinetix Investors...In doing some research with PKTX newest collaboration with Dr. Thomas Pulinilkunnil..The Pulinilkunnil laboratory will screen and examine the therapeutic utility of PKX-001 (AAGP®) against inflammatory, hypertrophic and ischemic pathologies in the heart..
....I found a short video on Dr. Thomas Pulinilkunnil and thought I would share the film with fellow Protokinetix Investors and introduce the gentleman..
***Upon the completion of this phase of testing, pre-clinicalscreening of organ preservation and metabolic effects of PKX-001 will be undertaken in transplant ready cardiac tissue. The overarching goal of this project is to develop PKX-001 as a cardioprotective agent with wide ranging applications in cardiovascular medicine.
Posts: 196 | From: Florida | Registered: Dec 2009
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
